Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (7,051,367)	$ (8,376,002)
Adjustment to reconcile net loss to net cash used in operating activities:
Stock based compensation	751,821	1,177,702
Interest accrued on note receivable	(26,717)
Write-off of construction-in-process	747,348
Depreciation and amortization	123,167	77,028
Changes in operating assets and liabilities:
Receivable due from collaboration agreement		(147,880)
Research and development tax incentive receivable	(24,906)	(108,097)
Prepaid assets and other current assets	685,328	237,646
Accounts payable	426,756	192,211
Accrued compensation	(4,430)	(416,910)
Deferred revenue	25,000	118,000
Operating lease obligation	(17,783)
Net cash used in operating activities	(4,365,783)	(7,246,302)
Cash flows from investing activities:
Purchases of property and equipment		(137,231)
Net cash used in investing activities		(137,231)
Cash flows from financing activities:
Payment of offering costs in connection with ATM	(17,920)
Net cash used in financing activities	(17,920)
Effect of exchange rate changes on cash and cash equivalents	(12,253)	3,031
Net change in cash and cash equivalents	(4,395,956)	(7,380,502)
Cash and cash equivalents at beginning of period	16,612,315	33,794,672
Cash and cash equivalents at end of period	12,216,359	26,414,170
Supplemental disclosure of non-cash investing and financing activities:
Purchases of equipment included in accounts payable		$ 338,674